Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AstraZeneca files sNDA with FDA for Casodex 150 mg

March 1, 2000

Alimta, a multitargeted antifolate: clinical experience outlined at ICACT

March 1, 2000

Phase I results support further evaluation of i.v. R-101933 + paclitaxel

March 1, 2000

Fujisawa backs Adherex and its novel cancer therapeutic

March 1, 2000

Progen uses Australian placement to advance development of PI-88

March 1, 2000

Cytoclonal isolates new class of genes involved in paclitaxel synthesis

March 1, 2000

Positive early clinical results for decitabine in advanced NSCLC

Feb. 29, 2000

Safety and efficacy of seocalcitol examined in phase II colorectal cancer study

Feb. 29, 2000

IRB approval received to commence phase II trial of GBC-590

Feb. 29, 2000

Lorus's lead anticancer products reduce tumor growth in mouse models of prostate cancer

Feb. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026